Predictive biomarkers for drug-resistant Acinetobacter baumannii isolates with blaTEM-1, AmpC-type bla and integrase 1 genotypes

Journal of Microbiology, Immunology and Infection

Volumn 39, Issue 5, 2006, Pages 372-379

  Chen, Chang Hua ^a,b   Young, Tzuu Guang ^c   Huang, Chieh Chen ^b  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

Acinetobacter baumannii; Bacterial drug resistance; Beta lactamases genetics; Biological markers; Genotype

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE AMPC; BETA LACTAMASE TEM 1; BIOLOGICAL MARKER; CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; FLOMOXEF; GENTAMICIN; INTEGRASE; INTEGRASE 1; NETILMICIN; OFLOXACIN; PIPERACILLIN; TAZOBACTAM; TETRACYCLINE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; CONTROLLED STUDY; ENZYME ASSAY; GENOTYPE; NONHUMAN; POLYMERASE CHAIN REACTION;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; BIOLOGICAL MARKERS; CEFTAZIDIME; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, BACTERIAL; GENTAMICINS; HUMANS; INTEGRASES; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PROSPECTIVE STUDIES; SPECIES SPECIFICITY; TAIWAN; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 33846032634     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Chen CH, Lin LC, Hwang KL. Nosocomial Acinetobacter baumannii bacteremia: comparison of the clinical manifestations of multiresistant strain and non-multiresistant strain infections. Changhua J Med 2002;7:86-92.
2. Chen CH, Lin LC, Chang YJ, Huang CC, Liu CE, Young TG. Analysis of prognostic factors in 95 patients with Acinetobacter baumannii baeteremia. Infection 2003;31:331-5.
3. Cisneros JM, Reyes MJ, Pachon J, Becerril B, Caballero FJ, Garcia-Garmendia JL, et al. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings and prognostic features. Clin Infect Dis 1996;22:1026-32.
4. Mammeri H, Poirel L, Mangeney N, Nordmann P. Chromosomal integration of a cephalosporinase gene from Acinetobacter baumannii into Oligella urethralis as a source of acquired resistance to beta-lactams. Antimicrob Agents Chemother 2003;47:1536-42.
5. Zarrilli R, Crispino M, Bagattini M, Barretta E, Di Popolo A, Triassi M, et al. Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance. J Clin Microbiol 2004;42:946-53.
6. Nagano N, Nagano Y, Cordevant C, Shibata N, Arakawa Y. Nosocomial transmission of CTX-M-2 beta-lactamase-producing Acinetobacter baumannii in a neurosurgery ward. J Clin Microbiol 2004;42:3978-84.
7. Craig WA. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn Microbiol Infect Dis 1995;22:89-96.
8. Gallego L, Towner KJ. Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from northern Spain. J Med Microbiol 2001;50:71-7.
9. Gombac F, Riccio ML, Rossolini GM, Lagatolla C, Tonin E, Monti-Bragadin C, et al. Molecular characterization of integrons in epidemiologically unrelated clinical isolates of Acinetobacter baumannii from Italian hospitals reveals a limited diversity of gene cassette arrays. Antimicrob Agents Chemother 2002;46:3665-8.
10. Koeleman JG, Stoof J, Van Der Bijl MW, Vanderbroucke-Grauls CM, Savelkou PH. Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR. J Clin Microbiol 2001;39:8-13.
11. Barbosa TM, Levy SB. The impact of antibiotic use on resistance development and persistence. Drug Resist Updat 2000;3:303-11.
12. Hanson ND. AmpC beta-lactamases: what do we need to know for the future? J Antimicrob Chemother 2003;52:2-4.
13. TEM genes. Antimicrob Agents Chemother 2000;44:2709-14.
14. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 9th informational supplement. NCCLS document M 100-S8. Wayne, Pa: National Committee for Clinical Laboratory Standards, 1998.
15. Bou G, Martínez-Beltrán J. Cloning, nucleotide sequencing and analysis of the gene encoding AmpC beta-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 2000;44:428-32.
16. Agarwal G, Kapil A, Kabra SK, Chandra R, Das B, Diwedi SN. Phenotypic and genotypic variants of Pseudomonas aeruginosa isolated from children with cystic fibrosis in India. Indian J Med Res 2002;116:73-81.
17. Lauderdale TL, McDonald LC, Shiau YR, Chen PC, Wang HY, Lai JF, et al. Vancomycin-resistant enterococci from humans and retail chickens in Taiwan with unique VanB phenotype-vanA genotype incongruence. Antimicrob Agents Chemother 2002;46:525-7.
18. Stefanelli P, Carattoli A, Neri A, Fazio C, Mastrantonio P. Prediction of decreased susceptibility to penicillin of Neisseria meningitidis strains by real-time PCR. J Clin Microbiol 2003;41:4666-70.
19. van Doorn LJ, Glupczynski Y, Kusters JG, Megraud F, Midolo P, Maggi-Solca N, et al. Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob Agents Chemother 2001;45:1500-4.
20. D'Agata E, Venkataraman L, DeGirolami P, Samore M. Molecular epidemiology of acquisition of ceftazidime-resistant gram-negative bacilli in a nonoutbreak setting. J Clin Microbiol 1997;35:2602-5.